SG Americas Securities’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-11,544
Closed -$92K 3026
2025
Q1
$92K Sell
11,544
-10,954
-49% -$87.3K ﹤0.01% 2726
2024
Q4
$122K Buy
22,498
+8,228
+58% +$44.6K ﹤0.01% 2309
2024
Q3
$103K Sell
14,270
-2,008
-12% -$14.5K ﹤0.01% 2720
2024
Q2
$177K Buy
+16,278
New +$177K ﹤0.01% 1972
2023
Q4
Sell
-18,607
Closed -$383K 3018
2023
Q3
$383K Buy
18,607
+1,847
+11% +$38K ﹤0.01% 1780
2023
Q2
$788K Buy
16,760
+5,668
+51% +$266K 0.01% 1052
2023
Q1
$465K Sell
11,092
-11,882
-52% -$498K 0.01% 1614
2022
Q4
$876K Buy
22,974
+12,482
+119% +$476K 0.01% 939
2022
Q3
$411K Sell
10,492
-13,989
-57% -$548K 0.01% 1521
2022
Q2
$791K Sell
24,481
-76,028
-76% -$2.46M 0.01% 1367
2022
Q1
$3.33M Buy
100,509
+86,031
+594% +$2.85M 0.02% 519
2021
Q4
$616K Sell
14,478
-53,272
-79% -$2.27M ﹤0.01% 1826
2021
Q3
$3M Buy
67,750
+43,599
+181% +$1.93M 0.01% 832
2021
Q2
$1.37M Buy
24,151
+4,281
+22% +$243K 0.01% 1228
2021
Q1
$1.49M Sell
19,870
-1,649
-8% -$123K 0.01% 1131
2020
Q4
$1.86M Buy
21,519
+4,088
+23% +$354K 0.01% 996
2020
Q3
$1.07M Buy
+17,431
New +$1.07M 0.01% 938
2019
Q4
Sell
-3,737
Closed -$524K 2793
2019
Q3
$524K Buy
3,737
+1,626
+77% +$228K ﹤0.01% 1611
2019
Q2
$387K Buy
2,111
+7
+0.3% +$1.28K ﹤0.01% 1778
2019
Q1
$335K Sell
2,104
-1,281
-38% -$204K ﹤0.01% 1912
2018
Q4
$324K Buy
3,385
+810
+31% +$77.5K ﹤0.01% 1815
2018
Q3
$364K Buy
2,575
+1,680
+188% +$237K ﹤0.01% 1999
2018
Q2
$140K Sell
895
-4,338
-83% -$679K ﹤0.01% 2490
2018
Q1
$843K Buy
+5,233
New +$843K 0.01% 1288
2017
Q4
Sell
-6,814
Closed -$425K 2905
2017
Q3
$425K Buy
6,814
+3,455
+103% +$215K ﹤0.01% 1717
2017
Q2
$268K Sell
3,359
-165
-5% -$13.2K ﹤0.01% 1976
2017
Q1
$250K Sell
3,524
-10,554
-75% -$749K ﹤0.01% 2033
2016
Q4
$719K Buy
14,078
+8,735
+163% +$446K 0.01% 1358
2016
Q3
$246K Buy
+5,343
New +$246K ﹤0.01% 2046
2015
Q4
Sell
-3,409
Closed -$144K 2426
2015
Q3
$144K Buy
+3,409
New +$144K ﹤0.01% 1646
2015
Q1
Sell
-4,305
Closed -$158K 2518
2014
Q4
$158K Buy
+4,305
New +$158K ﹤0.01% 2340